Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AHCO vs SIBN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
SIBN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)
SIBN Overall Winner
6-Pillar Tally: AHCO 3 – 3 SIBN
Matrix Metrics: AHCO 4 – 6 SIBN
As of Nov 20, 2026, SI-BONE, Inc. (SIBN) is the stronger overall head-to-head candidate over AdaptHealth Corp. (AHCO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). AHCO carries a Unified Composite Score of 45.2/100 (HOLD) at $7.20 (7.8x Forward P/E, 3.8% operating margin), whereas SIBN carries 53.5/100 (HOLD) at $23.73 (N/M Forward P/E, -7.6% operating margin).
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About AHCO vs SIBN
AHCO
AdaptHealth Corp. Common Stock
$7.20
-0.69% 1D
Market Cap
$989.8M
TTM Revenue
$3.44B
Forward P/E
7.8x
Beta / 30D Vol
0.17β · 67% Vol
Unified Composite Score
45.2
HOLD
Tech 29.0
Fund 46.0
Flow 54.0
Mom 60.0
Weinstein Technical Phase
Markup · Hold / add on dips
SIBN
Head-to-Head Winner
SI-BONE, Inc. Common Stock
$23.73
-0.08% 1D
Market Cap
$1.1B
TTM Revenue
$221M
Forward P/E
N/M
Beta / 30D Vol
0.65β · 74% Vol
Unified Composite Score
53.5
HOLD
Tech 45.0
Fund 57.0
Flow 72.0
Mom 56.1
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (AHCO 3 – 3 SIBN)
1. Valuation Multiples
AHCO
Forward P/E
7.8x
N/M
Trailing P/E
7.8x
N/M
PEG Ratio
N/M
N/M
EV / Revenue
0.9x
4.9x
2. Growth & Scale
SIBN
Revenue Growth (YoY)
+10.9%
+14.5%
Earnings Growth (YoY)
+6.7%
+0.0%
TTM Revenue (USD)
$3.44B
$221M
Market Cap
$989.8M
$1.1B
3. Profitability & Quality
SIBN
Gross Margin
18.2%
79.4%
Operating Margin
3.8%
-7.6%
Net Profit Margin
-11.8%
-6.2%
Return on Equity (ROE)
-28.4%
-7.7%
4. Balance Sheet & Cash Flow
AHCO
Cash Generation (TTM)
$82M
-$4.2M
Cash Flow Margin
2.4%
-1.9%
Net Cash / Leverage
$1.97B Net Debt (1.67x D/E)
$7.5M Net Debt (0.23x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
SIBN
Options Structure Phase
SURGE
BREAKOUT
Current IV / %ile
66.9% (12th %ile)
149.2% (48th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat
AHCO
OpEx & R&D Intensity
14.4% of Rev ($495M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Devices Operator
Medical Devices Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: AHCO (4) vs SIBN (6)| Institutional Metric | AHCO | SIBN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $989.8M | $1.1B | SIBN | |
| Trailing P/E Ratio | 7.8x | N/M | AHCO | |
| Forward P/E Ratio | 7.8x | N/M | AHCO | |
| Revenue Growth (YoY) | +10.9% | +14.5% | SIBN | |
| Operating Margin (TTM) | 3.8% | -7.6% | AHCO | |
| Net Profit Margin | -11.8% | -6.2% | SIBN | |
| Return on Equity (ROE) | -28.4% | -7.7% | SIBN | |
| 52-Week Range Position | 24% ($5–$13) | 85% ($11–$26) | SIBN | |
| Beta / 30D Volatility | 0.17β · 67% Vol | 0.65β · 74% Vol | AHCO | |
| Unified Institutional Score | 45.2 / 100 (HOLD) | 53.5 / 100 (HOLD) | SIBN | |
| Trailing 12M Revenue (USD) | $3.44B | $221M | Scale | |
| Gross Profit Margin (TTM) | 18.2% | 79.4% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.9x EV/Rev | N/M PEG · 4.9x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $82M ($1.97B Net Debt (1.67x D/E)) | -$4.2M ($7.5M Net Debt (0.23x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
AHCO +6.63 pp
3M Horizon
AHCO +6.01 pp
6M Horizon
SIBN +92.75 pp
1Y Horizon
SIBN +48.46 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AHCO Revenue | SIBN Revenue | AHCO Op. Margin | SIBN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $350M | $60M | 9.0% | -21.6% | AHCO |
| FY2019 | $530M | $70M | 5.5% | -53.5% | AHCO |
| FY2020 | $1.06B | $70M | 6.8% | -52.6% | AHCO |
| FY2021 | $2.45B | $90M | 9.2% | -57.3% | AHCO |
| FY2022 | $2.97B | $110M | 6.4% | -56.0% | AHCO |
| FY2023 | $3.20B | $140M | -18.7% | -33.8% | AHCO |
| FY2024 | $3.26B | $170M | 8.1% | -21.1% | AHCO |
| FY2025 | $3.24B | $200M | 2.8% | -11.1% | AHCO |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
AHCO
SURGE
Current IV
66.9%
IV Percentile
12th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact AHCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
SIBN
BREAKOUT
Current IV
149.2%
IV Percentile
48th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact SIBN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
AHCO Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
14.4% of Rev ($495M)
90D Engineering Disclosures
0 Published
SIBN Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ AHCO vs SIBN Key Questions & Quantitative Answers
As of Nov 20, 2026, SI-BONE, Inc. (SIBN) is the stronger overall head-to-head candidate over AdaptHealth Corp. (AHCO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). AHCO carries a Unified Composite Score of 45.2/100 (HOLD) at $7.20 (7.8x Forward P/E, 3.8% operating margin), whereas SIBN carries 53.5/100 (HOLD) at $23.73 (N/M Forward P/E, -7.6% operating margin). Technically, AHCO sits in a Markup phase (RSI 57.1, SURGE options structure) and SIBN sits in a Markup phase (RSI 57.6, BREAKOUT options structure).
SIBN leads the Growth & Scale pillar: AHCO posts +10.9% YoY revenue growth and +6.7% YoY earnings growth on $3.44B TTM revenue (18.2% gross margin, 3.8% operating margin), compared with SIBN at +14.5% YoY revenue growth and +0.0% YoY earnings growth on $221M TTM revenue (79.4% gross margin, -7.6% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AHCO cumulative revenue shifted +825.7% while SIBN shifted +233.3%. In operating R&D and SG&A reinvestment, AHCO deploys 14.4% of Rev ($495M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SIBN.
AHCO screens cheaper on headline valuation multiples. AHCO trades at 7.8x Forward P/E, 7.8x Trailing P/E, N/M PEG, and 0.9x EV/Revenue (2.4% FCF margin), whereas SIBN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 4.9x EV/Revenue (-1.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AHCO (-28.4% ROE) versus SIBN (-7.7% ROE) capital efficiency.
In options market volatility and institutional positioning, AHCO carries 66.9% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.17β · 67% Vol realized risk). By comparison, SIBN carries 149.2% implied volatility (48th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKOUT options structure phase (0.65β · 74% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
SIBN vs AHCO · Reverse Pair
AHCO vs OPCH
· Sector Peer
AHCO vs ADUS
· Sector Peer
AHCO vs RPAY
· Sector Peer
SIBN vs KIDS
· Sector Peer
SIBN vs VREX
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem